Back to 
Belvedere Trading LLC
Belvedere Trading LLC
TVTX
Showing 0 of 2 quarters
Position history for Belvedere Trading LLC's holdings in Travere Therapeutics, Inc.
No. Belvedere Trading exited its TVTX (Travere Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 7,877 shares worth $70,420. Belvedere Trading first reported TVTX in Q3 2023 and held it in 1 quarterly 13F filing.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.